Retno Danarti
Retno Danarti is an expert in Dermatology at Rumah Sakit Umum Pusat Dr. Sardjito (Indonesia). As of July 2026, ScienceLeadR ranks Retno Danarti in the top 1% of experts in Indonesia for Skin Abnormalities. Retno Danarti has authored 72 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 213 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Pediatrics - Pharmacy - Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2026
Number : 72
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Crusted scabies in patients with recessive dystrophic epidermolysis bullosa. PMID 42246326 — epidermolysis bullosa dystrophica, scabies, epidermolysis bullosa | Dermatol Online J | 2026 | 0 |
| Long-term survival in severe epidermolysis bullosa simplex with the potentially fatal KRT5 p.Glu477Lys variant. PMID 42064415 — epidermolysis bullosa simplex, epidermolysis bullosa | JAAD Case Rep | 2026 | 0 |
| Rapid growth of low-risk condyloma acuminata in an HIV-positive pregnant woman. PMID 41425041 — cd4 lymphocyte count, pregnant women, cells, t-lymphocytes, regulatory, pregnancy, growth, hiv, immunity, alphapapillomavirus, infections, human papillomavirus viruses | Indian J Sex Transm Dis AIDS | 2025 | 0 |
| Recurrent severe infections in a child with STAT3-associated hyper-IgE syndrome. PMID 41378312 — job syndrome, infections, child | JAAD Case Rep | 2025 | 0 |
| Nanotechnology in Infantile Hemangioma Management. PMID 39935564 — hemangioma, nanoparticles, pharmaceutical preparations, neoplasms, therapeutics, nanotechnology, laser therapy | J Pediatr Pharmacol Ther | 2025 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Ethosomal Gel Bearing Losartan 5 for Keloid Treatment NCT05893108 — injections, triamcinolone, angiotensin ii, triamcinolone acetonide, pharmaceutical preparations, cicatrix, keloid, losartan, angiotensins, injections, intralesional, therapeutics, pigmentation, erythema | Phase 1/Phase 2 | Not yet recruiting | 2024 |
LeadR Networks
Main global connection map